Tuesday, March 23, 2021 // 6:30- (EST)
Complimentary Live Virtual Program
Join Memorial Sloan Kettering (MSK) experts in the areas of bladder and kidney cancers for the Latest Treatment Advances in Bladder and Kidney Cancer, a complimentary CME event.
We will review the latest advances in robotic cystectomy and intracorporeal diversion for invasive bladder cancer. We will also explore the contemporary management of advanced kidney cancer and discuss genomic biomarkers in the treatment selection of advanced kidney cancer as well as a variety of other topics.
The intended audience for this program includes medical oncologists, urologists, internal and family medicine practitioners, and other affiliated healthcare professionals who are involved in the care of people with cancer or have a special interest in this area.
Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement
Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.